Latest Breaking News On - ஆரிப் னாதூ - Page 1 : comparemela.com
Reporting by Helen Popkin, Aayushi Pratap and Nina Wolpow
The Covid-19 pandemic was devastating for many industries, but it only accelerated the use of artificial intelligence across the U.S. economy. Amid the crisis, companies scrambled to create new services for remote workers and students, beef up online shopping and dining options, make customer call centers more efficient and speed development of important new drugs.
Even as applications of machine learning and perception platforms become commonplace, a thick layer of hype and fuzzy jargon clings to AI-enabled software.That makes it tough to identify the most compelling companies in the spaceâespecially those finding new ways to use AI that create value by making humans more efficient, not redundant.
Stanford
California
United-states
New-york
Afghanistan
Paris
France-general
France
Los-altos
Palo-alto
Philadelphia
Pennsylvania
Care Access Research has teamed up with
AstraZeneca to support the Phase III clinical trial for AZD7442, AstraZeneca’s long-acting monoclonal antibody combination for the potential prevention of COVID-19.
Using Care Access’s Mobile Sites On Demand, the two will develop, deploy and manage clinical research sites across the country to assess the safety and efficacy of AZD7442 for post-exposure prophylaxis and preemptive treatment.
“Traditional methods limit who can participate in a clinical trial and how quickly we can complete the clinical trial,” said Ahmad Namvargolian, CEO of Care Access, in a statement. “We are pleased to provide AstraZeneca the innovative capabilities they need to expedite clinical research operations for this important COVID-19 treatment candidate.”
Arif-nathoo
Ahmad-namvargolian
Leah-jones
Astrazeneca
Komodo-health
Blue-health-intelligence
Us-orthopedic-alliance
Care-access-research
Care-access
Mobile-sites-on-demand
Healthcare-map
Manik-bhat